Overview Assess the Efficacy and Safety of Rhinocort Aqua Status: Completed Trial end date: 2005-05-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare Rhinocort with placebo in pediatric subjects aged 2-5 years with allergic rhinitis to study effects on nasal symptoms such as sneezing, runny and stuffy noses. Phase: Phase 2 Details Lead Sponsor: AstraZenecaTreatments: Budesonide